ArticleFrontiers in endocrinology2026
Associations of CALLY, CLR, and CHR with all-cause mortality in patients receiving maintenance hemodialysis: a two-center retrospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients undergoing maintenance hemodialysis (MHD) remain at high risk of death. Composite inflammation-related indices may capture inflammatory burden, immune status, nutritional reserve, and lipid-related protective capacity. This study evaluated the associations of the C-reactive protein-albumin-lymphocyte (CALLY) index, C-reactive protein-to-lymphocyte ratio (CLR), and C-reactive protein-to-high-density lipoprotein cholesterol ratio (CHR) with all-cause mortality in patients receiving MHD. Methods: This retrospective two-center cohort study included adult patients undergoing maintenance hemodialysis at Shenzhen People's Hospital and Huidong People's Hospital, China. Baseline data were collected between January 2017 and October 2022, and all patients were followed until death or October 2023. CALLY, CLR, and CHR were natural log-transformed and analyzed using Cox proportional hazards models, Kaplan-Meier curves, restricted cubic splines, subgroup analyses, time-dependent receiver operating characteristic curves, and sensitivity analyses after multiple imputation. Results: During a median follow-up of 36.67 months (IQR, 20.01-52.80 months), 125 patients died. In the fully adjusted Cox models, each one-unit increase in ln CALLY was associated with lower all-cause mortality risk (HR, 0.85; 95% CI, 0.77-0.94; P = 0.002), whereas ln CLR (HR, 1.19; 95% CI, 1.06-1.33; P = 0.003) and ln CHR (HR, 1.18; 95% CI, 1.07-1.31; P = 0.002) were associated with higher mortality risk. Kaplan-Meier curves showed significant survival differences across tertiles (log-rank P = 0.016, 0.012, and 0.044). Restricted cubic spline analyses showed significant overall associations (P = 0.0158, 0.0138, and 0.0301) without significant nonlinearity. The 3-year AUCs were 0.603, 0.598, and 0.563 for ln CALLY, ln CLR, and ln CHR, respectively. Sensitivity analyses yielded similar Cox regression results. Conclusions: ln CALLY, ln CLR, and ln CHR were independently associated with all-cause mortality in MHD patients and may serve as accessible markers for initial prognostic risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.